These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6152138)

  • 1. [Use of beta-blockers in the acute phase of myocardial infarction].
    Marcillac-Desruennes M; Weber S; Degeorges M
    Ann Cardiol Angeiol (Paris); 1984 Dec; 33(8):519-23. PubMed ID: 6152138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of beta-adrenergic blocking agents in acute myocardial infarction (author's transl)].
    Wirtzfeld A; Klein G; Himmler FC; Schmidt G
    Herz; 1981 Apr; 6(2):73-83. PubMed ID: 6112196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Modulation of the beta-adrenergic system during acute myocardial infarction: rationale for a new clinical trial].
    Ibáñez B; Fuster V; Macaya C; Jiménez-Borreguero J; Iñiguez A; Fernández-Ortiz A; Sanz G; Sánchez-Brunete V
    Rev Esp Cardiol; 2011 Jul; 64 Suppl 2():28-33. PubMed ID: 21807284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myocardial infarction: secondary prevention with betablockers].
    Depelchin P; Hammoude H; Degré S
    Ann Cardiol Angeiol (Paris); 1989 Mar; 38(3):155-61. PubMed ID: 2567590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-adrenoceptor blockade and myocardial infarction: when should treatment start and for how long should it continue?
    Baber NS; Lewis JA
    Circulation; 1983 Jun; 67(6 Pt 2):I71-7. PubMed ID: 6133647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial infarction. Effects of beta-blockade.
    Hjalmarson A; Olsson G
    Circulation; 1991 Dec; 84(6 Suppl):VI101-7. PubMed ID: 1683604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Secondary prophylaxis with beta blockers after myocardial infarction].
    Bosković D
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():25-34. PubMed ID: 18193807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Beta-blockers in the acute phase of myocardial infarction. Echographic study].
    Hauer B; Grison D; Favier JP; Sacrez A
    Ann Cardiol Angeiol (Paris); 1985 Feb; 34(2):75-81. PubMed ID: 3885832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of treatments with beta-blockaders after myocardial infarction].
    Haïat R; Roussin I; Leroy G
    Arch Mal Coeur Vaiss; 1992 Nov; 85(11 Suppl):1697-702. PubMed ID: 1363902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rationale, design and organization of the Second Chinese Cardiac Study (CCS-2): a randomized trial of clopidogrel plus aspirin, and of metoprolol, among patients with suspected acute myocardial infarction. Second Chinese Cardiac Study (CCS-2) Collaborative Group.
    Second Chinese Cardiac Study (CCS-2) Collaborative Group
    J Cardiovasc Risk; 2000 Dec; 7(6):435-41. PubMed ID: 11189013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac protection during acute myocardial infarction: where do we stand in 2004?
    Kloner RA; Rezkalla SH
    J Am Coll Cardiol; 2004 Jul; 44(2):276-86. PubMed ID: 15261919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits of non-selective versus cardioselective beta-blockers in acute myocardial infarction in hypertensive patients.
    Hansen O; Johansson BW
    J Hypertens Suppl; 1993 Jun; 11(4):S55-60. PubMed ID: 8104242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of beta-blockers in the treatment of patients after infarction.
    Pratt CM; Young JB; Roberts R
    Cardiol Clin; 1984 Feb; 2(1):13-20. PubMed ID: 6152718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of ongoing trials of beta blockers in the secondary prevention of coronary heart disease.
    Cutler JA
    Circulation; 1983 Jun; 67(6 Pt 2):I62-5. PubMed ID: 6133645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Beta blockade in acute myocardial infarction].
    Bosković D; Terzić B; Perunicić J; Zugić M; Beleslin BD
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():17-24. PubMed ID: 18196643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Secondary prevention of myocardial infarct with beta blockers].
    Vacheron A; Baubion N; Delage F
    J Pharmacol; 1983; 14 Suppl 2():169-75. PubMed ID: 6138466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
    Piccini JP; Hranitzky PM; Kilaru R; Rouleau JL; White HD; Aylward PE; Van de Werf F; Solomon SD; Califf RM; Velazquez EJ
    Am J Cardiol; 2008 Dec; 102(11):1427-32. PubMed ID: 19026290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Beta blockers in secondary prevention following acute heart infarct].
    Kaufmann U
    Praxis (Bern 1994); 1995 Mar; 84(11):299-303. PubMed ID: 7724945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of viable myocardium early after acute myocardial infarction under beta-blockade by enoximone echocardiography.
    Natale E; Minardi G; Wang F; Tubaro M; Giovannini E; Vajola SF; Milazzotto F
    G Ital Cardiol; 1997 Apr; 27(4):342-8. PubMed ID: 9199952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infarct size reduction: a review of clinical trials.
    Fitzsimons TJ
    J Cardiovasc Pharmacol; 1989; 14 Suppl 9():S34-7. PubMed ID: 2483230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.